Short News
Real-time coverage of short selling positions, activist reports, regulatory actions, and corporate fraud investigations — rewritten and published as original, SEO-optimized financial journalism. Updated hourly.
NuScale Power Faces Securities Fraud Probe After UBS Downgrade
Following a sharp downgrade by UBS, law firms have initiated investigations into potential securities fraud at NuScale Power Corporation. The firm's analysis highlighted structural hurdles, including significant projected negative cash flows.
Gildan Activewear Faces Investor Scrutiny After Short Report
Following the release of a short-seller report, Gildan Activewear has become the subject of investor investigations. The firm's stock price decline has prompted legal firms to examine potential disclosure failures.
SEC Charges CMI Capital in Pension Fraud Case
The SEC has charged CMI Capital and its founder Michael D. Williams with operating an investment scheme that defrauded law enforcement officers, marking another case of affinity fraud targeting public servants.
Robinhood Crypto Insider Trading Case Highlights 'Shadow' Market Risks
Federal prosecutors have charged two former Robinhood engineers with fraud, revealing a critical blind spot in institutional compliance monitoring: employee trading on decentralized derivatives platforms.
FTAI Aviation Faces Dual Short-Seller Pressure and Class Action
FTAI Aviation Ltd. is under mounting pressure following a second critical report from Snowcap, which corroborates earlier allegations of financial irregularities raised by Muddy Waters Research.
X Corp Faces Scrutiny Over Potential Data Misuse Allegations
X Corp, formerly Twitter, is reportedly under investigation by the Federal Trade Commission (FTC) for potential violations of a 2022 consent order. The probe centers on allegations that the company misused user data for advertising purposes without adequate consent.
Andrew Left Conviction Marks Shift in Short-Seller Oversight
The recent criminal conviction of activist short seller Andrew Left for securities fraud signals a hardening regulatory stance on 'short-and-distort' tactics, focusing on trading practices rather than the veracity of research.
SEC Enforcement Pivot: Quality Over Quantity in 2026
The SEC’s Division of Enforcement has shifted toward a "back-to-basics" strategy, deprioritizing high-volume technical cases in favor of targeted fraud investigations.
Hindenburg Research Dissolution Marks End of an Era
The closure of Hindenburg Research, once the industry's most prominent short-selling firm, signals a major contraction in the activist short-selling sector following years of intense regulatory scrutiny.
Sportradar Class Action Follows Muddy Waters Allegations
Sportradar Group AG is facing a securities class action lawsuit following a 22% share price collapse triggered by critical reports from Muddy Waters Research and Callisto Research.
Federal Jury Convicts Short Seller in 'Short-and-Distort' Case
A federal jury has convicted an activist short seller of securities fraud, marking a significant milestone in the ongoing regulatory crackdown on 'short-and-distort' schemes.
Petrus Advisers Counters Grizzly Research in Raiffeisen Play
Activist investor Petrus Advisers has increased its stake in Raiffeisen Bank International following a sharp sell-off triggered by a report from short seller Grizzly Research.
Raiffeisen Bank Faces Volatility After Grizzly Research Report
Raiffeisen Bank International shares experienced significant turbulence following a critical report from short seller Grizzly Research, prompting a counter-move from activist investors.
JPMorgan Settles SEC Enforcement Actions for $151 Million
JPMorgan Chase affiliates have agreed to a $151 million settlement with the SEC to resolve multiple charges, including fiduciary breaches and misleading disclosures.
Raiffeisen Bank Shares Tumble Following Short-Seller Report
Raiffeisen Bank International shares experienced a sharp decline following the release of a new short-seller report, marking the bank's worst daily performance in over four years.
Grizzly Research Targets Raiffeisen Bank Over Russia Ties
Shares of Raiffeisen Bank International experienced a sharp decline following a new short position disclosure from Grizzly Research alleging problematic ties to Russia.
Andrew Left Conviction Marks New Era for Short Sellers
A federal jury has convicted activist short seller Andrew Left on 13 counts of securities fraud, signaling a heightened regulatory focus on 'short-and-distort' trading strategies.
Sportradar Faces Class Action Following Short Seller Allegations
Sportradar Group AG is the subject of a securities class action lawsuit following a 22% share price collapse triggered by critical reports from Muddy Waters and Callisto Research.
Andrew Left Convicted: A New Precedent for Short Activism
The conviction of prominent activist short seller Andrew Left on securities fraud charges marks a watershed moment for market regulation, shifting the focus from the veracity of research to the mechanics of trade execution.
The "Short-and-Distort" Precedent: A Mid-Year Review of the Andrew Left Verdict
Following the June 2026 conviction of Citron Research founder Andrew Left, the market continues to grapple with the implications of the first successful criminal prosecution of an activist short seller focused on trading strategy rather than report content.
Federal PPP Enforcement Surge Targets Pandemic-Era Fraud
A nationwide federal enforcement initiative has resulted in action against 160 defendants and the suspension of 870,000 individuals from future government-backed loans, marking a major escalation in the recovery of pandemic-era fraud.
BlackRock Discloses Short Position in Beijer Ref
BlackRock Advisors has initiated a public short position in Swedish refrigeration wholesaler Beijer Ref, signaling potential institutional bearishness in the industrial sector.
Citadel Advisors Discloses Short Position in Vicore Pharma
Citadel Advisors has officially entered the short-selling landscape for Vicore Pharma, disclosing a position exceeding 0.5 percent of the company's shares.
Sportradar Faces Scrutiny Over Alleged Illegal Betting Ties
Sportradar shares plummeted 23% following coordinated reports from Muddy Waters and Callisto Research alleging systemic regulatory failures.
SDNY Enters Final Consent Judgment Against Ex-Doximity CRO Over Insider Selling
A federal court in New York has finalized a civil consent judgment against former Doximity revenue chief Paul Jorgensen, imposing a permanent officer-and-director bar and resolving parallel SEC insider trading claims.
Haywood USA Fined $750,000 by SEC Over Cross-Border AML and Red-Flag Deficiencies
The SEC has penalized Canadian broker-dealer subsidiary Haywood Securities (USA) $750,000 for systemic failures in monitoring high-risk accounts and filing required Suspicious Activity Reports on micro-cap transactions.
Citadel Advisors Crosses Swedish Disclosure Threshold in Vicore Pharma Short
Citadel Advisors has become a public short seller in Sweden's Vicore Pharma after crossing the 0.5% net short position threshold. Regulatory disclosures from Finansinspektionen show total aggregate short interest standing at 2.76%.
Andrew Left Criminal Conviction Reshapes Activist Short Selling Playbook
Following the criminal securities fraud conviction of Citron Capital founder Andrew Left, the activist short-selling space faces unprecedented legal scrutiny. The verdict establishes sharp boundaries between research-driven short selling and illicit 'short and distort' trading schemes.
Short Sellers Target Australian Uranium and Tech in Systematic Rotation
Short sellers are ramping up scrutiny across Australian-listed clean tech, uranium producers, and media giants, as capital shifts highlight operational bottlenecks and debt structures.
SEC Files Fraud Charges in $1.5M Impersonation and SAFE Offering Scheme
The SEC has charged CleverProfits founder Adam Rundle with running a $1.5 million offering fraud using fabricated Simple Agreements for Future Equity (SAFEs) and identity theft of a licensed financial adviser.
SEC Targets Phantom Adviser Invesco Alpha in $1.18M Default Judgment
A federal court in Colorado has entered a $1.18 million default judgment against Invesco Alpha Inc. following SEC charges alleging fabricated Form ADV disclosures. The case highlights aggressive enforcement against entity impersonation and paper-only investment advisers.
SEC Rebuilds Specialized Accounting Fraud Enforcement Unit
The Securities and Exchange Commission has formalized the launch of its dedicated Financial Reporting and Accounting Unit under Enforcement Chief David Woodcock. The return to specialized balance-sheet forensics marks a shift back toward complex corporate disclosure cases.
Short Sellers Adopt 'Left Disclosures' to Shield Trading
Following the criminal conviction of Citron Research founder Andrew Left, major short sellers including Muddy Waters and Jehoshaphat Research have overhauled their report disclaimers. The explicit disclosure that funds may cover immediately upon publication reflects a structural defensive pivot across activist desks.
AQR Capital Discloses Public Short Position in Getinge
AQR Capital Management has disclosed an initial 0.50 percent public short position in Swedish medtech supplier Getinge. The disclosure highlights growing institutional focus as total short interest climbs to 3.37 percent.
Andrew Left Convicted of Fraud in Landmark Short-Selling Trial
Citron Research founder Andrew Left has been convicted on 13 criminal counts of securities fraud in federal court. The verdict establishes a historic legal precedent regarding the boundary between market commentary and fraudulent trading execution.
Citron Founder Andrew Left Convicted in Landmark U.S. Criminal Trial
Andrew Left, founder of prominent short-seller Citron Research, has been found guilty of securities fraud in U.S. federal court. The landmark verdict culminates parallel actions by the DOJ and SEC over allegations of deceptive public commentary and manipulative trading.
Activist Short Industry Faces Contraction Under DOJ Scrutiny and New Disclosure Regimes
Recent federal prosecutions and expanded SEC disclosure mandates under Rule 13f-2 are compounding structural headwinds for activist short sellers. With short-bias funds dropping by over 70% since 2008, forensic operators face escalating legal, financial, and regulatory friction.
Andrew Left Faces Criminal Fraud Trial in Los Angeles as Short Selling Reckoning Arrives
Citron Research founder Andrew Left heads to trial in Los Angeles federal court over DOJ and SEC allegations of orchestrating a multi-year short-and-distort scheme. The landmark prosecution highlights the growing legal boundary between legitimate forensic research and illicit pre-publication front-running.
Sportradar Hit with Securities Class Action Following Short Campaign
Sportradar Group faces a new investor class action alleging misleading statements about revenue legitimacy, following research published by Muddy Waters and Callisto Research that erased over $800 million in market capitalization.
SEC Enforcement Hits Record $8.2B in Fiscal 2024
The U.S. Securities and Exchange Commission concluded fiscal year 2024 with a record-breaking $8.2 billion in financial remedies, signaling an aggressive posture toward corporate misconduct.
Datavault AI Shares Drop Following Short Report
Datavault AI shares experienced a significant decline following a short-seller report questioning the validity of the company's announced partnerships.
DOJ and SEC Escalate Scrutiny Over Activist Short-and-Distort Trading Patterns
Federal prosecutors and securities regulators are intensifying their enforcement actions against activist short sellers who manipulate timing and misrepresent positions. Forensic trading data and regulatory milestones indicate that mismatched price targets and rapid covering are now primary prosecution targets.
Wolfpack Research Short Attack Triggers Securities Fraud Suits Against Flotek
Flotek Industries faces mounting securities class actions following a devastating report by short seller Wolfpack Research. The report exposed that a centerpiece $400 million contract with Puerto Rico's power authority was terminated amidst regulatory reviews.
Viceroy Escalates Blue Moon Metals Short Campaign with Regulatory Petitions
Activist short seller Viceroy Research has petitioned the EFTA Surveillance Authority to intervene against Blue Moon Metals' flagship Norwegian project. The firm alleges material environmental permitting failures and undisclosed regulatory barriers at the company's planned Nussir copper mine.
SEC Standalone Enforcement Actions Drop to Decade Low of 313 in 2025
Recent data compiled by law firm Paul Weiss reveals the U.S. Securities and Exchange Commission initiated only 313 standalone enforcement actions in 2025, marking a ten-year low. Structural shifts, including tighter Commissioner oversight on formal investigation orders, have coincided with a steep 27% year-over-year decline in enforcement volume.
Sportradar Faces Securities Litigation Over Activist Short Seller Claims
Sportradar Group AG is facing a newly filed federal securities class action stemming from an activist short seller report alleging an illegal underlying business model. The case highlights the accelerating speed at which forensic short dossiers translate into formal shareholder litigation.
DOJ and SEC Short-and-Distort Crackdown Tests Activist Boundaries
Federal prosecutors and the SEC have escalated parallel enforcement actions against activist short seller Andrew Left and Citron Capital. The charges focus on alleged front-running, misrepresenting trading intentions, and executing rapid position reversals around published research.
Activist Short Seller Andrew Left Convicted on Federal Securities Fraud Charges
Citron Capital founder Andrew Left has been convicted by a federal jury in Los Angeles on multiple counts of securities fraud. The verdict marks a watershed moment in regulatory enforcement against activist short sellers engaged in alleged market manipulation.
PROCEPT BioRobotics (NASDAQ: PRCT) Faces Securities Fraud Class Action Alleging Discount-Driven Revenue Inflation and Overstated Handpiece Utilization
SBS Law has announced a securities fraud class action against PROCEPT BioRobotics (NASDAQ: PRCT) alleging the company used large discounts to incentivize bulk orders — pulling revenue forward at the expense of future periods — and materially overstated the utilization of its handpiece units. Lead-plaintiff deadline is September 22, 2026.
Cardinal Infrastructure (NASDAQ: CDNL) Shares Plunge 36% After A.L. Grading Acquisition Issues Surface in Q2 2026 Results — BFA Law Opens Securities Fraud Probe
BFA Law has opened a securities fraud investigation into Cardinal Infrastructure Group (NASDAQ: CDNL) after the stock collapsed 36% on August 11, 2026, when Q2 2026 results revealed a 12.4% adjusted EBITDA margin — far below the 20%+ margin Cardinal had guided — due to cost overruns and scalability issues tied to the A.L. Grading Contractors acquisition.
Pentair plc (NYSE: PNR) Faces Securities Fraud Class Action After CFO Exit and ~$170M Pool-Channel Destocking Hit
Kaplan Fox has alerted Pentair plc (NYSE: PNR) investors to an October 2, 2026 lead-plaintiff deadline in a securities fraud class action alleging misleading statements concealed a pool-channel inventory destocking that the company ultimately disclosed as a ~$170 million sales impact — a correction that emerged alongside the departure of Pentair's CFO.
Capricor Therapeutics (NASDAQ: CAPR) Faces Securities Fraud Class Action; Lead-Plaintiff Deadline September 28, 2026
Kaplan Fox has alerted Capricor Therapeutics (NASDAQ: CAPR) investors to a September 28, 2026 lead-plaintiff deadline in a securities fraud class action covering the December 2025–July 2026 class period, alleging the company made materially false and misleading statements about its business and prospects that left the market uninformed about risks that subsequently materialized.
Guggenheim Strategic Opportunities Fund (NYSE: GOF) Securities Fraud Investigation Continues After Short-Seller Report on Premium-Share-Funded Distributions
A law firm investigation into possible securities violations by Guggenheim Strategic Opportunities Fund (NYSE: GOF) is continuing after a short-seller report alleged the fund's distributions were funded by selling shares at a premium to NAV — a circular structure that, if true, would mean distributions were financed by dilution rather than portfolio returns — with the probe unfolding against the backdrop of a federal investigation into Guggenheim CEO Mark Walter.
Bloom Energy (NYSE: BE) Faces Securities Fraud Class Action Over Alleged Undisclosed Chinese Scandium Sourcing
Kaplan Fox has alerted investors to a September 28, 2026 lead-plaintiff deadline in a securities fraud class action against Bloom Energy Corporation (NYSE: BE) alleging the company understated its reliance on Chinese-sourced scandium obtained through intermediaries — a material supply-chain dependency the plaintiffs say was concealed from investors despite being load-bearing for the company's clean-energy production model.
Dick's Sporting Goods (NYSE: DKS) Faces Securities Fraud Class Action Over Foot Locker Acquisition Disclosures
A securities fraud class action has been filed against Dick's Sporting Goods (NYSE: DKS) alleging investors were misled about the inventory position and integration challenges following its acquisition of Foot Locker — with executives accused of painting an unduly rosy picture of the post-acquisition integration while concealing material inventory and operational risks that subsequently materialized.
Kaplan Fox Alerts Investors to Securities Fraud Class Action Against Wix.com Ltd. Over Alleged AI Competitive Edge Misrepresentations
Kaplan Fox & Kilsheimer LLP has alerted investors to a securities fraud class action against Wix.com Ltd. (NASDAQ: WIX) over a February 19, 2025–May 12, 2026 class period, alleging executives misled the market by falsely claiming proprietary AI tools gave Wix a strong competitive edge — when rival AI platforms rapidly outpaced it and internal operational costs accelerated, until a May 13, 2026 Q1 earnings miss and margin drop triggered a 27.1% single-day stock collapse ($20.56 per share).
Rosen Law Firm Files Securities Class Action Against Wise Group plc Over Alleged AML Compliance Failures
The Rosen Law Firm has filed a federal securities class action against Wise Group plc (WISE) on behalf of investors who purchased securities between May 11 and July 23, 2026, alleging management issued false and misleading statements about the stability of its global cross-border payments infrastructure while concealing systemic deficiencies in its anti-money laundering and counter-terrorism financing compliance controls — exposing the firm to severe regulatory backlash and operational delays just as CFO Emmanuel Thomassin is set to face investors at the Goldman Sachs Communacopia + Technology Conference.
Kerrisdale Capital: Affirm Is a Subprime Lender in the Political Crosshairs — "Buy Now, Cry Later"
Kerrisdale Capital published a short report on Affirm Holdings arguing the $25B BNPL lender is a subprime balance-sheet lender charging 31% average loan yields, now exposed to a proposed 10% credit card APR cap, with thin reserves against 6-7% historical loss rates and a $17 fair value estimate (~80% downside). The claims are allegations by a disclosed short seller, not adjudicated facts.
Kerrisdale Capital: Everspin Is a Casino-Gaming Memory Supplier, Not an AI Winner
Kerrisdale Capital published a short report on Everspin Technologies arguing the ~$900M MRAM chipmaker's 300% stock surge is an AI mania misfire — its largest end market is casino gaming, not hyperscalers — and its valuation multiples are disconnected from years of stagnant ~$55-65M revenue. The claims are allegations by a disclosed short seller, not adjudicated facts.
Viceroy Research: Close Brothers Faces a Redress Bill It Cannot Absorb — and an FCA Complaint Over Its Own Disclosure
Viceroy Research published a sequence of reports alleging Close Brothers Group has understated its exposure to the FCA's Motor Finance Consumer Redress Scheme by hundreds of millions of pounds, culminating in a formal letter of complaint to the FCA alleging the bank's 8 April 2026 announcement was materially misleading. The claims are allegations by a disclosed short seller — not adjudicated facts.
Viceroy Research: Vedanta Gets Raided by India's Enforcement Directorate Over Alleged FEMA Violations
Viceroy Research reported that India's Enforcement Directorate raided Vedanta Limited on 2 June 2026 over alleged FEMA violations connected to brand-fee payments to UK parent Vedanta Resources, corroborated by Indian media reporting a share-price drop. The article also summarizes Viceroy's prior allegations of VRL defaults, a concealed 2023 ED meeting, and ESG failures at Vedanta's Chhattisgarh plant — all allegations by a disclosed short seller, not adjudicated facts.
Viceroy Research Goes Short on Abaxx Technologies: 'Liquidity Explosion at the Plumbing Factory'
Viceroy Research published a follow-up short report on Abaxx Technologies on 30 June 2026, alleging that statements made by management on a June 26 ATB investor call confirm a large share of the exchange's reported trading volume and open interest is incentivized rather than organic, and raising related-party and disclosure questions. The claims are allegations by a disclosed short seller — not adjudicated facts.
Viceroy Research Goes Short on Blue Moon Metals (Nussir): 'Norway Finds No-Way to Dump in Fjords'
Viceroy Research published a short report on Blue Moon Metals on 8 September 2026, centered on an August 27, 2026 letter in which Norway's Environment Ministry allegedly admits its fjord-tailings permitting guidance is legally deficient — potentially revoking Nussir's disposal permit and exposing a shaky $140 million financing package. The claims are allegations by a disclosed short seller — not adjudicated facts.
Muddy Waters Goes Short on AppLovin (NASDAQ: APP): 'Just Another Scammy AdTech Company'
Muddy Waters Research published a short report on AppLovin Corporation (NASDAQ: APP) on 27 March 2025, alleging ~52% of e-commerce conversions are retargeting, true incrementality is only ~25-35%, ~23% Q1 client churn, and that APP's business is built on systematically violating third-party platforms' TOS via 'Persistent Identity Graphs' — risking deplatforming à la Cheetah Mobile. The claims are allegations by a disclosed short seller — not adjudicated facts.
Muddy Waters Goes Short on SoFi (NASDAQ: SOFI): Booking a $312M JPMorgan Loan as a 'Sale'
Muddy Waters Research published a follow-up short report on SoFi Technologies (NASDAQ: SOFI) on 30 March 2026, alleging management booked a $312 million JPMorgan loan as a loan sale, with Utah UCC filings contradicting the accounting — requiring a restatement of ~$1 billion of EBITDA and materially lower capital ratios. The claims are allegations by a disclosed short seller — not adjudicated facts.
Muddy Waters Goes Short on Sportradar (NASDAQ: SRAD): 'Putting the BET into Aiding and Abetting'
Muddy Waters Research published a short report on Sportradar Group AG (NASDAQ: SRAD) on 22 April 2026, alleging the sports-data integrity leader actively aids and abets illegal gambling across black and grey markets — backed by an undercover ICE 2026 sting, ~15 employee interviews, code analysis, a 20–40% illegal-revenue estimate, and ~50 named illegal-market clients. The claims are allegations by a disclosed short seller — not adjudicated facts.
Muddy Waters Goes Short on Ensign (NASDAQ: ENSG): The 'Rented License' Thesis
Muddy Waters Research published a short report on The Ensign Group (NASDAQ: ENSG) on 11 June 2026, alleging a systematic 'rented license' scheme at ~20% of its skilled nursing facilities, theoretical False Claims Act sanctions in the billions, ~210 bps of margin compression, and ~35% lower 2027 EBIT under compliance. The claims are allegations by a disclosed short seller — not adjudicated facts.
White Diamond Research's 25-Cent Target on Blaize Holdings: The Case of the Unpaid AI Contracts
White Diamond Research's short report on Blaize Holdings (BZAI) sets a 25-cent price target, citing a $120 million Starshine Computing agreement of which the company has reported receiving only $1.6 million, a newer $50 million NeoTensr deal that generated $20 million in recognized revenue with no disclosed cash collected, a thinly documented counterparty behind that deal, and two prior short-seller reports the company never publicly rebutted.
White Diamond Research's $1 Target on Microbot Medical: What the Surgeons Who Actually Used the LIBERTY Robot Are Saying
White Diamond Research's short report on Microbot Medical (MBOT) sets a $1 price target after interviewing two vascular surgeons who used the company's LIBERTY Endovascular Robotic System — one calling it 'extra work' with no reimbursement code, the other using it only about once a week at Tampa General — plus a former employee who described gaps in the company's reimbursement strategy, drawing a parallel to founder Harel Gadot's prior venture, XACT Robotics, which shut down in 2023.
White Diamond Research Short SEGG Media: An Inactive Domain, a Dozen Unconfirmed Press Releases, and a Pending SEC Fraud Case
White Diamond Research's short report on SEGG Media alleges the company's sports.com domain has remained an inactive email-collection landing page since 2021 despite years of promotional press releases about expansions and partnerships, questions the legitimacy of its newly announced Polymarket partnership given the lack of any confirmation from Polymarket, and notes SEGG faces a pending SEC civil fraud action along with five other active lawsuits and delinquent 2025 SEC filings.
White Diamond Research Short Quantum Cyber: A CEO's 477 Million Convertible Shares and a Broken-Website Drone Partner
White Diamond Research's short report on Quantum Cyber (QUCY) — formerly molecular diagnostics firm Mainz Biomed — alleges CEO David Lazar holds a convertible security exercisable at roughly $0.013 per share that could push the fully diluted share count to nearly 500 million against 22.77 million reported shares outstanding. The report also finds QUCY's BP United drone license partner has a broken website with $0.00-priced products, and that its Project LightShift quantum antenna deal has no verifiable public history predating the announcement.
White Diamond Research Short RTB Digital: The $200 Million Media Platform With 50 Monthly Visitors
White Diamond Research's short report on RTB Digital (NASDAQ: RTB) — formerly RYVYL, formerly Greenbox POS — alleges its Roundtable crypto-media platform receives only about 50 website visits per month despite a market cap exceeding $200 million after a 300% rally. The report finds roughly 41 verified publisher sites against a claimed 200, flags the flagship deal as a related-party transaction, and notes the predecessor RYVYL settled SEC fraud charges over fabricated blockchain claims in April 2026.
White Diamond Research Short ZenaTech: CEO-Controlled Epazz Sold Tech Back to ZenaTech at 19x Book Value
White Diamond Research's short report on ZenaTech (ZENA) alleges the company advanced roughly C$28.2 million in cash to Epazz — a tiny OTC company controlled by ZenaTech's own CEO — for R&D, then paid $46.5 million in ZenaTech stock for the resulting technology, which Epazz's own filing valued at just $2.36 million in book value, roughly 19 times book. The report also flags approximately 86 million common-equivalent shares from convertible preferred stock that it says are missing from standard dilution trackers.
Grizzly Research Short Ottobock: The €1.5 Billion Margin Loan, 35% of Profits From Russia, and the Accounting Trickery Behind a €3.8 Billion IPO
Grizzly Research's short report on Ottobock (IS44.DE) alleges majority shareholder Hans Georg Näder has pledged all 81% of his shares in a €1.5 billion PIK margin loan accumulating interest at ~15% p.a., the company derives an estimated 35.1% of net income from Russia, and aggressive accounting — R&D capitalization, Russia consolidation without disclosure, extended depreciation — artificially inflates earnings. The firm estimates fair value at €30 against a €3.8 billion IPO valuation.
Grizzly Research Short Pirelli: 10% of Profits From Russia, Kirov Factory Feeding the Military Complex, and an Undercover Path to Tires for Russian Forces in Ukraine
Grizzly Research's short report on Pirelli (PIRC.MI) alleges roughly 10% of the Italian tire maker's profits come from Russia — far more than its folded disclosures imply — and that its Kirov factory shares infrastructure with a neighboring Russian state-owned plant producing tires for military vehicles including the RS-24 Yars nuclear-warhead launcher. An undercover operation found Pirelli's Russian hotline willing to share a contact for buying tires for a Russian military unit fighting in Ukraine, and a dealer in occupied Donetsk is still listed on Pirelli's website.
Grizzly Research Short 2CRSi: Fabricated US Revenue, $610M Phantom Contract, and a Veterinarian's Animal Hospital at the Center of an Undisclosed Related-Party Scheme
Grizzly Research's short report on French server-maker 2CRSi alleges nearly all US revenue is fabricated through an undisclosed related-party scheme centered on Joseph Church, a veterinarian with no data-center experience whose companies are headquartered in a Plattsburgh, NY animal hospital. The $610M contract client was created on the day of the announcement, its website built by 2CRSi's own IT department, and its CEO appears as 'Co-founder' on the client's fundraising deck.
Federal Court Upholds SEC Fraud Action Against Andrew Left
A federal judge rejected Citron Research founder Andrew Left's bid to dismiss the SEC's civil fraud lawsuit. The ruling reinforces that activist short sellers cannot publicly issue price targets while secretly trading against their own published guidance.
Fluence Discloses Formal SEC Probe Following Short-Seller Report
Fluence Energy reveals that the SEC has launched a formal investigation into its financial reporting following an internal inquiry initiated by an activist short campaign.
Andrew Left Found Guilty in Benchmark Securities Fraud Trial
Citron Research founder Andrew Left has been convicted on 13 counts of securities fraud in federal court. The landmark verdict penalizes near-publication trading mismatches and sets a chilling precedent for activist short sellers.
Andrew Left Securities Fraud Conviction Accelerates Chill Across Short Activism
The conviction of Citron Capital founder Andrew Left on federal securities fraud charges marks a transformative shift in regulatory posture against activist short sellers. Market participants warn the verdict risks shrinking the public forensic research space at a time when short activity has already fallen substantially.
Andrew Left Conviction Redefines Legal Boundaries for Activist Short Sellers
The criminal conviction of Citron Research founder Andrew Left marks an unprecedented enforcement turning point for activist short sellers. Regulators successfully proved securities fraud based on trading execution and rapid position reversals rather than factual falsehoods in underlying research.
GPGI Class Action Spotlight Highlights Husky Acquisition Pitfalls
Investor lawsuits against GPGI, Inc. near class certification deadlines following forensic short-seller scrutiny and severe margin deterioration post-Husky Technologies acquisition. The case exposes aggressive M&A projection practices.
DOJ Charges Linqto Founder in $450M Pre-IPO Markup Scheme
Federal prosecutors unsealed an indictment against Linqto founder William Sarris, alleging a massive scheme that deceived 13,000 retail buyers with undisclosed 200% markups on private shares. The case spotlights acute valuation opacity across secondary private tech platforms.
SEC Targets ISS in Subpoena Escalation Over Voting Guidance
The SEC filed a federal subpoena enforcement action to compel proxy giant Institutional Shareholder Services to hand over core voting and recommendation records. The action signals an aggressive regulatory push into proxy advisory governance and fiduciary compliance.
Shortfinder Publishes Activist Short Report on Achieve Life Sciences (ACHV)
Shortfinder published an activist short report on Achieve Life Sciences (NASDAQ: ACHV) on 4 September 2026, alleging the stock is overvalued at a 12-month high on an unapproved drug candidate, with ~68% projected share-count dilution and a newly filed $150M ATM despite ~$187M cash on hand — framing approval as a potential exit event for existing holders. The claims are allegations, not established fact.
SEC and DOJ Intensify Regulatory Reckoning for Activist Short Sellers
Parallel civil and criminal actions targeting short-and-distort schemes signal a fundamental shift in how regulators police public short campaigns. Forensic scrutiny is now turning directly on the gap between an activist's public thesis and their real-time trading executions.
SEC Realigns Enforcement Arm Around Dedicated Accounting Unit
Legal experts and market watchdogs analyzing SEC Chairman Paul Atkins' directives highlight the agency's newly formed Financial Reporting and Accounting Unit as its core engine for policing public balance sheets, auditor independence, and aggressive earnings recognition.
SEBI Convenes Hearings to Claw Back $22M From Hindenburg-Linked Trades
India's market regulator has initiated formal personal hearings to recover $22.25 million in alleged illicit gains tied to short positions established ahead of Hindenburg Research's 2023 Adani report. The cross-border enforcement proceeding challenges offshore jurisdictional limits for activist short sellers.
Quinn Emanuel Breach Compromises Muddy Waters Work Product
Elite litigation firm Quinn Emanuel Urquhart & Sullivan disclosed that files belonging to activist short seller Muddy Waters were compromised in a cyber breach. The incident adds institutional operational risk to the ongoing legal crossfire between Carson Block's research outfit and corporate adversaries.
SEC and DOJ Scrutiny of Short Activism Accelerates Ahead of Rule 13f-2
Parallel SEC and DOJ enforcement actions targeting activist short-and-distort campaigns highlight heightened regulatory risks for activist research shops. The scrutiny coincides with the SEC's Rule 13f-2 disclosure regime requiring monthly Form SHO filings.
SEC Enforces New Rule 13f-2 Short Disclosures as Scrutiny Mounts
Following high-profile parallel enforcement actions against activist short sellers, the Securities and Exchange Commission's new Rule 13f-2 framework establishes aggressive disclosure requirements for institutional short positions. Markets now face aggregate public short reporting starting in April 2025.
DOJ and SEC Crack Down on Activist Short Sellers Over Scalping Tactics
Parallel federal enforcement actions and convictions targeting activist short sellers signal an aggressive crackdown on scalping and short-and-distort schemes. As the SEC ramps up disclosure requirements via Rule 13f-2 and Form SHO, market participants face unprecedented scrutiny over the timing of their public commentary versus actual trading execution.
DOJ and SEC Regulatory Clampdown Reshapes Short Activism Disclosure
Parallel civil and criminal actions against prominent activist short sellers highlight increased enforcement focus on short-and-distort schemes. Coupled with mandatory Form SHO reporting under Rule 13f-2, regulatory agencies are systematically shrinking the room for anonymous and rapidly reversed activist positions.
The Precedent of the Andrew Left Conviction
The recent criminal conviction of activist short seller Andrew Left marks a significant shift in how regulators approach 'short-and-distort' campaigns, focusing on trading behavior rather than the veracity of research.
Fragmented Oversight: Navigating the Global Short-Selling Compliance Minefield
As the UK implements its Short Selling Regulation 2025, global firms face an increasingly complex web of divergent disclosure thresholds and enforcement priorities.
Subprime ABS Fraud: The $1.9B ‘Double-Pledge’ Scheme Charges
The SEC unsealed charges this week against former executives of a defunct subprime auto lender, alleging they double-pledged $1.9 billion in auto loan receivables to defraud ABS investors.
Linqto Indictment: The Manufactured Scarcity of Pre-IPO Markets
Federal prosecutors have unsealed an indictment against Linqto founder William Sarris, alleging a multi-year scheme to defraud investors through excessive markups and manufactured scarcity on the pre-IPO platform.
Photronics Deadline: The $1.1 Billion ‘Detection Gap’ of 2026
As the September 4 lead plaintiff deadline arrives for Photronics (PLAB) investors, the company’s 36% single-day crash in May remains a cautionary tale of unmonitored design release bottlenecks and the widening 'detection gap' in activist research.
Transparency as a Weapon: Analyzing the SEC’s 2026 Short Disclosure Mandate
New SEC rules requiring prompt disclosure of short positions by hedge funds aim to enhance market transparency but may fundamentally alter the economics of activist research.
Greenwashing as Alpha: Sunlight Partners and the ESG Short Frontier
Brisbane-based Sunlight Partners has reported a 12% gain following a campaign against Babcock & Wilcox, signaling a shift toward environmental forensic analysis in the short-selling space.